| scholarly article | Q13442814 |
| P2093 | author name string | C J L M Meijer | |
| P J F Snijders | |||
| J Berkhof | |||
| B I Witte | |||
| M C G Bleeker | |||
| R Ridder | |||
| M H Uijterwaal | |||
| F J Van Kemenade | |||
| D Rijkaart | |||
| G A M A Balfoort-van der Meij | |||
| P2860 | cites work | Problems of spectrum and bias in evaluating the efficacy of diagnostic tests | Q28275783 |
| Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities | Q30456505 | ||
| High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance | Q30664084 | ||
| Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population | Q34543338 | ||
| HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study | Q35262983 | ||
| HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications | Q35835143 | ||
| Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses | Q36584432 | ||
| Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results | Q36740209 | ||
| Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study | Q37135912 | ||
| Developing role of HPV in cervical cancer prevention | Q38127410 | ||
| Management of the low-grade abnormal Pap smear: What are women's preferences? | Q43634266 | ||
| The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results | Q44068170 | ||
| Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion | Q44451879 | ||
| Sensitivity and specificity of a single diagnostic test in the presence of work-up bias | Q44507713 | ||
| CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion | Q46543020 | ||
| Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. | Q50770674 | ||
| Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. | Q51201676 | ||
| Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study). | Q51794674 | ||
| Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. | Q53028990 | ||
| p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. | Q54600679 | ||
| Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. | Q54770367 | ||
| Overview of the European and North American studies on HPV testing in primary cervical cancer screening | Q57414808 | ||
| Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial | Q61626075 | ||
| Observer agreement on interpreting colposcopic images of CIN | Q71919575 | ||
| High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy | Q73824709 | ||
| Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation | Q73879814 | ||
| Comparisons of predictive values of binary medical diagnostic tests for paired designs | Q73946335 | ||
| Criteria for organized cervical screening programs. Special emphasis on The Netherlands program | Q74532219 | ||
| Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months | Q79926062 | ||
| The nocebo effect for women in waiting | Q80184807 | ||
| Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
| Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| P304 | page(s) | 1579-1586 | |
| P577 | publication date | 2014-02-11 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study | |
| P478 | volume | 110 |
| Q64937296 | Application of p16/Ki-67 dual-staining cytology in cervical cancers. |
| Q88381375 | Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up |
| Q41027688 | Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). |
| Q59354820 | Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women |
| Q37225246 | Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China |
| Q48110805 | Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. |
| Q91803351 | Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study |
| Q40525853 | Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN. |
| Q40373166 | Indications for p16/Ki-67 in cervical cytology |
| Q47792379 | Intra- and inter-observer reproducibility of CINtec® PLUS in ThinPrep® cytology preparations |
| Q91967903 | Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology |
| Q64109841 | Progress in immunocytochemical staining for cervical cancer screening |
| Q55060965 | Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. |
| Q38205174 | The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments |
| Q38824019 | Triage of high-risk HPV positive women in cervical cancer screening. |
| Q30274986 | Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial |
| Q36852263 | Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women |
| Q52846008 | [Modern biomarkers for precancerous lesions of the uterine cervix : Histological-cytological correlation and use]. |
| Q40767169 | p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population |
Search more.